Discovery and Mechanistic Studies of Dual-Target Hits for Carbonic Anhydrase IX and VEGFR-2 as Potential Agents for Solid Tumors: X-ray, In Vitro, In Vivo, and In Silico Investigations of Coumarin-Based Thiazoles.

A dual-targeting approach is predicted to yield better cancer therapy outcomes. Consequently, a series of coumarin-based thiazoles (5a-h, 6, and 7a-e) were designed and constructed as potential carbonic anhydrase (CA) and VEGFR-2 suppressors. The inhibitory actions of the target compounds were assessed against CA isoforms IX and VEGFR-2. The assay results showed that coumarin-based thiazoles 5a, 5d, and 5e can effectively inhibit both targets. 5a, 5d, and 5e cytotoxic effects were tested on pancreatic, breast, and prostate cancer cells (PANC1, MCF7, and PC3). Further mechanistic investigation disclosed the ability of 5e to interrupt the PANC1 cell progression in the S stage by triggering the apoptotic cascade, as seen by increased levels of caspases 3, 9, and BAX, alongside the Bcl-2 decline. Moreover, the in vivo efficacy of compound 5e as an antitumor agent was evaluated. Also, molecular docking and dynamics displayed distinctive interactions between 5e and CA IX and VEGFR-2 binding pockets.

[1]  C. Supuran,et al.  Discovery of Novel Pyridazine-Tethered Sulfonamides as Carbonic Anhydrase II Inhibitors for the Management of Glaucoma. , 2024, Journal of medicinal chemistry.

[2]  Wagdy M. Eldehna,et al.  Development of new thieno[2,3-d]pyrimidines as dual EGFR and STAT3 inhibitors endowed with anticancer and pro-apoptotic activities. , 2024, Bioorganic chemistry.

[3]  Marwa M. Abu‐Serie,et al.  Challenging the anticolorectal cancer capacity of quinoxaline-based scaffold via triazole ligation unveiled new efficient dual VEGFR-2/MAO-B inhibitors. , 2024, Bioorganic chemistry.

[4]  Hamada S. Abulkhair,et al.  Design, synthesis, and mechanistic insight of novel imidazolones as potential EGFR inhibitors and apoptosis inducers. , 2024, Bioorganic chemistry.

[5]  M. Liaghat,et al.  Promising applications of nanotechnology in inhibiting chemo-resistance in solid tumors by targeting epithelial-mesenchymal transition (EMT). , 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[6]  Li Liu,et al.  New pyrimidinothiophene derivatives: Synthesis, spectroscopic analysis, X-ray, DFT calculation, biological activity studies and ADMET prediction , 2023, Journal of Molecular Structure.

[7]  M. Prashanth,et al.  Design, synthesis, anticancer activity and docking studies of novel quinazoline-based thiazole derivatives as EGFR kinase inhibitors , 2023, Heliyon.

[8]  Wagdy M. Eldehna,et al.  Novel 4-(2-arylidenehydrazineyl)thienopyrimidine derivatives as anticancer EGFR inhibitors: Design, synthesis, biological evaluation, kinome selectivity and in silico insights. , 2023, Bioorganic chemistry.

[9]  H. Sugiyama,et al.  Anticancer Activities of DNA-Alkylating Pyrrole-Imidazole Polyamide Analogs Targeting RUNX Transcription Factors against p53-Mutated Pancreatic Cancer PANC-1 Cells. , 2023, Journal of medicinal chemistry.

[10]  Ahmed B. M. Mehany,et al.  Recruitment of hexahydroquinoline as anticancer scaffold targeting inhibition of wild and mutants EGFR (EGFRWT, EGFRT790M, and EGFRL858R) , 2023, Journal of enzyme inhibition and medicinal chemistry.

[11]  S. Alshawwa,et al.  Unveiling the antitumor potential of novel N-(substituted-phenyl)-8-methoxycoumarin-3-carboxamides as dual inhibitors of VEGFR2 kinase and cytochrome P450 for targeted treatment of hepatocellular carcinoma , 2023, Frontiers in chemistry.

[12]  Tamer M. Ibrahim,et al.  Discovery of indolinone-bearing benzenesulfonamides as new dual carbonic anhydrase and VEGFR-2 inhibitors possessing anticancer and pro-apoptotic properties. , 2023, European journal of medicinal chemistry.

[13]  C. Supuran.  A simple yet multifaceted 90 years old, evergreen enzyme: Carbonic anhydrase, its inhibition and activation. , 2023, Bioorganic & medicinal chemistry letters.

[14]  R. Allam,et al.  Novel quinoxaline-based VEGFR-2 inhibitors to halt angiogenesis. , 2023, Bioorganic chemistry.

[15]  C. Supuran,et al.  Discovery of sulfonamide-tethered isatin derivatives as novel anticancer agents and VEGFR-2 inhibitors , 2023, Journal of enzyme inhibition and medicinal chemistry.

[16]  S. Gou,et al.  Design, synthesis, and biological evaluation of novel HDAC inhibitors with a 3-(benzazol-2-yl)quinoxaline framework. , 2023, Bioorganic & medicinal chemistry letters.

[17]  M. Gouda,et al.  Synthesis, DNA-Binding, Molecular Docking, and Cytotoxic Activity of a New 4-Amino-N-(5-selenocyanatothiazol-2-yl) benzenesulfonamide , 2023, Journal of Molecular Structure.

[18]  Zhi‐Xin Guo,et al.  A Mild Oxidative Bromination of Ketones with The Combination of Kbr/ Fe(No3)3·9h2o , 2023, SSRN Electronic Journal.

[19]  S. H. Cardoso,et al.  Coumarin-Based Compounds as Inhibitors of Tyrosinase/Tyrosine Hydroxylase: Synthesis, Kinetic Studies, and In Silico Approaches , 2023, International journal of molecular sciences.

[20]  S. Carradori,et al.  Coumarin-pyrazoline hybrids as selective inhibitors of the tumor-associated carbonic anhydrase IX and XII. , 2023, Anti-cancer agents in medicinal chemistry.

[21]  C. Supuran,et al.  Terminators or Guardians? Design, Synthesis, and Cytotoxicity Profiling of Chalcone-Sulfonamide Hybrids , 2023, ACS omega.

[22]  M. Kandil,et al.  Coumarin derivatives with potential anticancer and antibacterial activity: Design, synthesis, VEGFR‐2 and DNA gyrase inhibition, and in silico studies , 2023, Drug development research.

[23]  J. Stanslas,et al.  One-pot two-component synthesis of halogenated xanthone, 3-o substituted xanthone, and prenylated xanthone derivatives as aromatase inhibitors , 2023, Results in Chemistry.

[24]  S. Antar,et al.  Ligand-Based Design on the Dog-Bone-Shaped BIBR1532 Pharmacophoric Features and Synthesis of Novel Analogues as Promising Telomerase Inhibitors with In Vitro and In Vivo Evaluations. , 2022, Journal of medicinal chemistry.

[25]  M. Sugiura,et al.  Synthesis, crystallographic, DNA binding, and molecular docking/dynamic studies of a privileged chalcone-sulfonamide hybrid scaffold as a promising anticancer agent , 2022, Journal of biomolecular structure & dynamics.

[26]  C. Supuran,et al.  Dependence on linkers’ flexibility designed for benzenesulfonamides targeting discovery of novel hCA IX inhibitors as potent anticancer agents , 2022, Journal of enzyme inhibition and medicinal chemistry.

[27]  Y. M. Lee,et al.  Steppogenin suppresses tumor growth and sprouting angiogenesis through inhibition of HIF-1α in tumors and DLL4 activity in the endothelium. , 2022, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[28]  S. Gou,et al.  Design, synthesis and anticancer evaluation of selective 2,4-disubstituted pyrimidine CDK9 inhibitors. , 2022, European journal of medicinal chemistry.

[29]  E. Shiferaw,et al.  Hematological abnormalities before and after initiation of cancer treatment among breast cancer patients attending at the University of Gondar comprehensive specialized hospital cancer treatment center , 2022, PloS one.

[30]  T. C. Elebiyo,et al.  Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy. , 2022, Cancer treatment and research communications.

[31]  C. Supuran,et al.  Novel 3-(6-methylpyridin-2-yl)coumarin-based chalcones as selective inhibitors of cancer-related carbonic anhydrases IX and XII endowed with anti-proliferative activity , 2022, Journal of enzyme inhibition and medicinal chemistry.

[32]  A. Veselovsky,et al.  New Genetic Bomb Trigger: Design, Synthesis, Molecular Dynamics Simulation, and Biological Evaluation of Novel BIBR1532-Related Analogs Targeting Telomerase against Non-Small Cell Lung Cancer , 2022, Pharmaceuticals.

[33]  Mohamed S. Nafie,et al.  Exploration of novel VEGFR2 tyrosine kinase inhibitors via design and synthesis of new alkylated indolyl-triazole Schiff bases for targeting breast cancer. , 2022, Bioorganic chemistry.

[34]  S. Fu,et al.  The Research Progress of Antiangiogenic Therapy, Immune Therapy and Tumor Microenvironment , 2022, Frontiers in Immunology.

[35]  C. Supuran,et al.  Discovery of new carbonic anhydrase IX inhibitors as anticancer agents by toning the hydrophobic and hydrophilic rims of the active site to encounter the dual-tail approach. , 2022, European journal of medicinal chemistry.

[36]  Mohamed A. Abdelrahman,et al.  Discovery of 2,4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms , 2022, Journal of enzyme inhibition and medicinal chemistry.

[37]  Enrico Klotzsch,et al.  The solid tumor microenvironment—Breaking the barrier for T cells , 2021, BioEssays : news and reviews in molecular, cellular and developmental biology.

[38]  S. Kabilan,et al.  Synthesis, Spectral, Crystal structure, Hirshfeld surface, Computational analysis, and Antimicrobial studies of Ethyl-(E)-4-(2-(2-arylidenehydrazinyl)-2-oxoethyl)piperazine-1-carboxylates , 2021, Journal of Molecular Structure.

[39]  C. Supuran,et al.  Natural inspired ligustrazine-based SLC-0111 analogues as novel carbonic anhydrase inhibitors. , 2021, European journal of medicinal chemistry.

[40]  C. Kulkarni,et al.  A facile one pot multi component synthesis of alkyl 4-oxo-coumarinyl ethylidene hydrazono-thiazolidin-5-ylidene acetates and their antiviral activity , 2021, Journal of Molecular Structure.

[41]  S. Kojima,et al.  Design, synthesis, and target identification of new hypoxia-inducible factor 1 (HIF-1) inhibitors containing 1-alkyl-1H-pyrazole-3-carboxamide moiety. , 2021, Bioorganic & medicinal chemistry.

[42]  Andrew A. Beharry,et al.  A Green-Absorbing, Red-Fluorescent Phenalenone-Based Photosensitizer as a Theranostic Agent for Photodynamic Therapy. , 2021, ACS medicinal chemistry letters.

[43]  C. Supuran,et al.  Novel benzenesulfonamides aryl and arylsulfone conjugates adopting tail/dual tail approaches: Synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies. , 2021, European journal of medicinal chemistry.

[44]  Aiping Lu,et al.  ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties , 2021, Nucleic Acids Res..

[45]  K. Mortezaee,et al.  Angiogenesis as a hallmark of solid tumors - clinical perspectives , 2021, Cellular Oncology.

[46]  C. Supuran,et al.  Synthesis and biological evaluation of novel 4, 7-disubstituted coumarins as selective tumor-associated carbonic anhydrase IX and XII inhibitors. , 2021, Bioorganic & medicinal chemistry letters.

[47]  M. Nistér,et al.  VEGFR2 inhibition hampers breast cancer cell proliferation via enhanced mitochondrial biogenesis , 2021, Cancer biology & medicine.

[48]  M. Hsieh,et al.  Cell cycle arrest and apoptosis induction by Juniperus communis extract in esophageal squamous cell carcinoma through activation of p53‐induced apoptosis pathway , 2020, Food science & nutrition.

[49]  Abolfazl Olyaei,et al.  One‐pot synthesis of novel ( E )‐3‐(3, 8a‐dihydro‐2 H ‐oxazolo[3,2‐a]pyridin‐2‐ylidene)chroman‐2‐one derivatives , 2020 .

[50]  X. Qian,et al.  Design, synthesis, and in vitro and in vivo anti-angiogenesis study of a novel vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor based on 1,2,3-triazole scaffold. , 2020, European journal of medicinal chemistry.

[51]  S. Dedhar,et al.  Interplay of Carbonic Anhydrase IX With Amino Acid and Acid/Base Transporters in the Hypoxic Tumor Microenvironment , 2020, Frontiers in Cell and Developmental Biology.

[52]  Hongmei Guo,et al.  Selective Debromination of α,α,α‐Tribromomethylketones with HBr–H 2 O Reductive Catalytic System , 2020 .

[53]  L. Zeferino,et al.  Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis , 2020, BMC Cancer.

[54]  Nermeen M. El Bakary,et al.  Role of Bee Venom and Melittin on Restraining Angiogenesis and Metastasis in γ-Irradiated Solid Ehrlich Carcinoma-Bearing Mice , 2020, Integrative cancer therapies.

[55]  Fan Sun,et al.  Low-dose photodynamic therapy-induced increase in the metastatic potential of pancreatic tumor cells and its blockade by simvastatin. , 2020, Journal of photochemistry and photobiology. B, Biology.

[56]  Y. Bansal,et al.  Inducible nitric oxide synthase inhibitors: A comprehensive update , 2020, Medicinal research reviews.

[57]  Juan Wang,et al.  Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus , 2020, Frontiers in Cellular and Infection Microbiology.

[58]  G. Ramírez-García,et al.  Microwave‐assisted synthesis and luminescent activity of imidazo[1,2‐ a ]pyridine derivatives , 2020 .

[59]  E. Giovannetti,et al.  3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1H-Indole Derivatives as New Anticancer Agents in the Treatment of Pancreatic Ductal Adenocarcinoma , 2020, Molecules.

[60]  S. Awale,et al.  Chemical Constituents of Anneslea fragrans and Their Antiausterity Activity against the PANC-1 Human Pancreatic Cancer Cell Line. , 2019, Journal of natural products.

[61]  S. C. Chafe,et al.  Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia. , 2019, Gastroenterology.

[62]  Abdul-Malek S. Al-Tamimi,et al.  Carbonic anhydrase inhibitors based on sorafenib scaffold: Design, synthesis, crystallographic investigation and effects on primary breast cancer cells. , 2019, European journal of medicinal chemistry.

[63]  S. Singh,et al.  Daucosterol disturbs redox homeostasis and elicits oxidative-stress mediated apoptosis in A549 cells via targeting thioredoxin reductase by a p53 dependent mechanism. , 2019, European journal of pharmacology.

[64]  C. Supuran,et al.  Design, synthesis and biological evaluation of coumarin-3-carboxamides as selective carbonic anhydrase IX and XII inhibitors. , 2019, Bioorganic chemistry.

[65]  Ahmed M. El Kerdawy,et al.  New thiazol-hydrazono-coumarin hybrids targeting human cervical cancer cells: Synthesis, CDK2 inhibition, QSAR and molecular docking studies. , 2019, Bioorganic chemistry.

[66]  Z. Seferoğlu,et al.  Improved one-pot synthetic conditions for synthesis of functionalized fluorescent coumarin-thiophene hybrids: Syntheses, DFT studies, photophysical and thermal properties , 2019, Tetrahedron.

[67]  Han Liu,et al.  Synthesis of gold nanoparticles from leaf Panax notoginseng and its anticancer activity in pancreatic cancer PANC-1 cell lines , 2019, Artificial cells, nanomedicine, and biotechnology.

[68]  Wei-Ting Chen,et al.  Thermal cycling-hyperthermia in combination with polyphenols, epigallocatechin gallate and chlorogenic acid, exerts synergistic anticancer effect against human pancreatic cancer PANC-1 cells , 2019, bioRxiv.

[69]  Anika C. Bundscherer,et al.  Staurosporine induces apoptosis in pancreatic carcinoma cells PaTu 8988t and Panc-1 via the intrinsic signaling pathway , 2019, European Journal of Medical Research.

[70]  Z. Seferoğlu,et al.  Proton Sensitive Functional Organic Fluorescent Dyes Based on Coumarin-imidazo[1,2-a ]pyrimidine; Syntheses, Photophysical Properties, and Investigation of Protonation Ability , 2018, European Journal of Organic Chemistry.

[71]  C. Supuran,et al.  Assessment of the antiproliferative and apoptotic roles of sulfonamide carbonic anhydrase IX inhibitors in HeLa cancer cell line , 2018, Journal of enzyme inhibition and medicinal chemistry.

[72]  Chu Tang,et al.  Novel Hybrid Conjugates with Dual Suppression of Estrogenic and Inflammatory Activities Display Significantly Improved Potency against Breast Cancer. , 2018, Journal of medicinal chemistry.

[73]  S. Bhattacharya,et al.  Indole-3-Carbinol (I3C) enhances the sensitivity of murine breast adenocarcinoma cells to doxorubicin (DOX) through inhibition of NF-κβ, blocking angiogenesis and regulation of mitochondrial apoptotic pathway. , 2018, Chemico-biological interactions.

[74]  C. Supuran,et al.  Selective inhibition of carbonic anhydrase-IX by sulphonamide derivatives induces pH and reactive oxygen species-mediated apoptosis in cervical cancer HeLa cells , 2018, Journal of enzyme inhibition and medicinal chemistry.

[75]  Ming Zhang,et al.  AuIII‐Catalyzed Formation of α‐Halomethyl Ketones from Terminal Alkynes , 2017 .

[76]  U. Rashid,et al.  Design, synthesis, antibacterial activity and docking study of some new trimethoprim derivatives. , 2016, Bioorganic & medicinal chemistry letters.

[77]  M. Narayan,et al.  Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition , 2016, Scientific Reports.

[78]  C. De Monte,et al.  Synthesis and pharmacological screening of a large library of 1,3,4-thiadiazolines as innovative therapeutic tools for the treatment of prostate cancer and melanoma. , 2015, European journal of medicinal chemistry.

[79]  C. Supuran,et al.  Efficient Expression and Crystallization System of Cancer-Associated Carbonic Anhydrase Isoform IX. , 2015, Journal of medicinal chemistry.

[80]  Berk Hess,et al.  GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers , 2015 .

[81]  Min Zhang,et al.  The Roles of ROS and Caspases in TRAIL-Induced Apoptosis and Necroptosis in Human Pancreatic Cancer Cells , 2015, PloS one.

[82]  N. Fujii,et al.  Design, synthesis, and structure-activity relationships of 1-ethylpyrazole-3-carboxamide compounds as novel hypoxia-inducible factor (HIF)-1 inhibitors. , 2015, Bioorganic & medicinal chemistry.

[83]  A. Alizadeh,et al.  An efficient synthesis of pyrrolo[2,1-a]isoquinoline derivatives containing coumarin skeletons via a one-pot, three-component reaction , 2015, Research on Chemical Intermediates.

[84]  Ji-Xin Cheng,et al.  Direct Visualization of De novo Lipogenesis in Single Living Cells , 2014, Scientific Reports.

[85]  S. Carradori,et al.  Synthesis of a novel series of thiazole-based histone acetyltransferase inhibitors. , 2014, Bioorganic & medicinal chemistry.

[86]  M. Mimeault,et al.  Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells , 2013, Journal of cellular and molecular medicine.

[87]  Abdussalam Salhin,et al.  Flow Injection Analysis of Mercury Using 4-(Dimethylamino) Benzaldehyde-4-Ethylthiosemicarbazone as the Ionophore of a Coated Wire Electrode , 2012, Sensors.

[88]  M. McTigue,et al.  Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors , 2012, Proceedings of the National Academy of Sciences.

[89]  Chun-ling Xiao,et al.  Synthesis and In‐Vitro Antimycobacterial Activity of Fluoroquinolone Derivatives Containing a Coumarin Moiety , 2011, Archiv der Pharmazie.

[90]  H. Osman,et al.  Synthesis and antimicrobial properties of some new thiazolyl coumarin derivatives. , 2011, European journal of medicinal chemistry.

[91]  C. Supuran,et al.  Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target. , 2010, Biochimica et biophysica acta.

[92]  A. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[93]  E. Novellino,et al.  Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization. , 2012, European journal of medicinal chemistry.